FDA 483 - DSAART LLC - June 26, 2025

DSAART LLC received a Form FDA 483 citing numerous deficiencies across its quality system, including inadequate corrective and preventive actions, unvalidated manufacturing processes, and a lack of established design controls. The inspection also highlighted issues with complaint handling, late MDR submissions, and insufficient risk analysis, indicating systemic failures in maintaining a compliant quality management system.